Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Melanoma treatment details. Biologic therapy. Royal Prince Alfred Hospital, Sydney, Australia

Survival: N/R
Toxicity Grade: 4
Treatments: Biologic therapy
Country: Australia
City/State/Province: Sydney
Hospital: Royal Prince Alfred Hospital
Journal: Link
Date: 6/2005

Patients: This Phase II study involved 15 patients with metastatic melanoma.

Treatment: The treatment consisted of a form of biological therapy - SAM486A, an inhibitor of S-adenosylmethionine decarboxylase (SAMDC). SAMDC is an enzyme that affects polyamine synthesis and polyamines are essential molecules for cell growth and proliferation.

Toxicity: Grade 4 toxicities included neutropenia. Grade 1-3 toxicities included fatigue, lethargy, and myalgia.

Results: There were no complete or partial responses.

Support: The study was sponsored by Novartis AG, the manufacturer of SAM486A.

Correspondence: Michael J. Millward, MD

E-mail to a Friend Email Physician More Information